SparkLabs Partners (CEO Kim Ho-min), a venture capital firm within SparkLabs Group, announced on the 22nd that it will establish a clinical specialty hospital and build a bio cluster in the Pohang region. To this end, SparkLabs Partners signed a four-party business agreement with Handong Global University, Pohang Technopark, and the Korea Angel Investment Association at Handong Global University's Hyeondong Hall.
Through this agreement, the institutions will collaborate to build an integrated bio cluster, including ▲ fostering clinical-focused bio startups, ▲ jointly promoting medical science and bio research across industry, academia, and research, ▲ securing investment resources and establishing strategies, ▲ conducting clinical trials and providing research infrastructure, and ▲ promoting verification and commercialization.
This project aims to foster Pohang as a bio-innovation hub, encompassing clinical research through technology commercialization, by bringing together local medical institutions, research institutes, and private investors, and to establish a growth ladder for bio-startups leveraging the region's medical infrastructure.
Kim Ho-min, CEO of SparkLabs Partners, said, “Due to the lack of clinical trial facilities in Korea, many clinical trials have been conducted overseas. By establishing a clinical specialty hospital, we will implement a clinical-centered bio cluster model and develop Pohang into a global bio hub.”
- See more related articles
You must be logged in to post a comment.